MS-BASED UNTARGETED PROTEOMICS AND METABOLOMICS:
CANCER METABOLISM, THERAPEUTIC TARGETS AND BIOMARKERS

It is for us a pleasure to announce the II "INTERNATIONAL PROTEOMICS & METABOLOMICS CONFERENCE AND ADVANCED SCHOOL" that will take place in Verona (Italy) in July 2019.
This will be conference organized in collaboration with the Division of Mass Spectrometry (DSM) and with the patronage of the Italian Cell Culture Association (AICC).

The objective of the conference is to present the recent advances in the proteomics and metabolomics analyses from cancer metabolism, to therapeutic targets detection and clinic.

Proteomics aims at the identification of biomarkers that can help in the diagnosis, prognosis and that can be useful as therapeutic targets. On the other hand, metabolites are closely related to the phenotypes of living organisms: the metabolomics profiling of biological fluids and cells can help to identify novel therapeutic targets, and can be useful to explain cell metabolism. Among the different metabolites, lipids play a key role in the reprogramming of cancer metabolism.

The conference will illustrate several applications of MS-based proteomics and metabolomics analysis to the study of cancer. Different strategies for the discovery of new therapeutic targets in cancer, as well as for study cancer metabolism will be described. Particular attention will be given to the role of lipids in cancer, and to the role of -omics in translational medicine for the screening and stratification of cancer patients.

As post-conference event, the Advanced School "Bioinformatics tools for mass mass-spectrometry based omic data: from pathways reconstruction to multi-omic data integration” will take place, bringing additional scientific value to the event. The Advanced School is aimed to give advanced education in bioinformatics analysis of omics data to graduate, PhD, post-doc students, and young scientists working in the areas of untargeted proteomics and metabolomics.

The Conference and the Advanced School will take place on the 1-2 July 2019 at the University of Verona, Italy. Verona is a city on the Adige river in Veneto, Italy. The city has been declared a World Heritage Site by UNESCO because of its urban structure and architecture. It is one of the main tourist destinations in northern Italy, because of its artistic heritage and several annual fairs, shows, and operas, such as the lyrical season in the Arena, the ancient amphitheater built by the Romans. Two of William Shakespeare's plays are set in Verona: Romeo and Juliet and The Two Gentlemen of Verona.
The Organizing Committee is preparing an exciting scientific program, covering various topics, including cancer metabolism, therapeutic targets and biomarkers. A preliminary programme of the Conference is already available in this webpage and will be updated regularly.

It is our pleasure to announce that the Opening Lecture of the conference will be given by Prof. Michael Wakelam, (Babraham Institute in Cambridge) for his outstanding contribution to the MS-based lipidomic field.
In summary, we invite you to come to Verona and join us for this exciting meeting that we are sure will be a reference event for the MS-based untargeted Proteomics and Metabolomics field in 2019.


Important Dates:
  • 1 February 2019 Call for Abstracts
  • 1 February 2019 Online registration opening
  • 15 May 10 June 2019 Deadline for abstracts submission
  • 1 June 10 June 2019 Abstract notification
  • 7 June 25 June 2019 Registration closure